« Let's Recap Public-Private R&D Collaborations | Main | Piramal finally falls to Abbott in India »



TrackBack URL for this entry:

Listed below are links to weblogs that reference Is the "Big" in Big Pharma a value creator or a liability? :


Feed You can follow this conversation by subscribing to the comment feed for this post.


Sanofi-Aventis has been successful in acquiring elements of its pipeline through small acquisitions. Its CEO says they remain on the hunt for further such opportunities - especially in the cancer area.


Zacks.com provides analysis of recent merger activity and what to look for in the coming year.


Fortune's take on Pharma and Biotech relationship coming out of BIO meetings in early June.

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC

visited 6 states (46.1%)
Create your own visited map of Canada